Monday, 2nd July First Malaria World Congress 2018

• Health, Malaria and Human Security - Khuat Thi Hai Oanh
• Malaria Today - Pedro Alonso
• An overview of the global burden of malaria - Simon Hay

• How Eradication and Elimination programmes contribute to Global Health Security - David Heymann
• Malaria: A Risk to Health Security in the Pacific Region - Jimmie Rodgers

Panel Discussion: "Malaria Today & Health Security"

• Professor David Heymann - London School of Hygiene and Tropical Medicine; Head of the Centre on Global Health Security at Chatham House, London
• Peter Versegi - Australian Ambassador for Regional Health Security
• Dr Pedro Alonso - Director of the WHO Global Malaria Programme
• Dr Jimmy Rogers - Board member of the Asia-Pacific Leaders Malaria Alliance
• Dr Khuat Thi Hai Oanh - Founder and Executive Director of the Centre for Supporting Community Development Initiatives

Hon Julie Bishop MP, Minister for Foreign Affairs, Government of Australia and member of the End Malaria Council
"Towards Malaria Elimination in the Indo-Pacific Region"

Panel Discussion "Malaria Elimination: Whose business is it?"

• Dr Winnie Mpanju-Shumbusho, Board Chair, RBM Partnership to End Malaria
• Lelio Marmora, Unitaid
• Dr David Reddy, Medicines for Malaria Venture

• Effective Malaria Frontline approaches - Scott Filler
• Country-driven, country-owned : The E-2020 initiative - Kim Lindblade
• Strengthening systems for sustainable suppression and elimination of malaria transmission - Justin Cohen

Q&A discussion to close

• Development of serological markers for detecting recent exposure to Plasmodium vivax malaria - Rhea J Longley
• Systems-based approaches to defining effective targets for intervention against malaria - Denise Doolan
• Implications for population immunity & the hidden benefits of malaria elimination   - Kevin Marsh
• How can immunopathology research and immunomodulation help malaria eradication? - Georges Grau
• Identifying new hit molecules – alternative strategies - Vicky Avery
• PfSR25, a malarial GPCR-like receptor that mediates extracellular K⁺ sensing coupled to Ca²⁺ signaling, antimalarial action and stress survival. - Celia Garcia
• Biochemical screens reveal that a high proportion of antimalarial drug candidates from phenotypic screens target PfATP4 - Kiaran Kirk
• Low dose primaquine for reducing Plasmodium falciparum transmission: systematic review and meta-analysis. - Patricia M Graves

• Recent changes in disease burden from malaria and other causes, 2000-2016: evidence from the Global Burden of Disease Study - Alan Lopez
• Temporal strain structure and responses to interventions in a high endemicity region of Plasmodium falciparum. - Karen P Day
• Mapping human mobility for malaria elimination planning - Caroline Buckee
• What have we learnt about community involvement from control to elimination of malaria - Maxine Whittaker
• Lessons from the Pacific - Vanuatu: Working with Communities for elimination - Len Tarivond
• Supporting all to achieve and sustain malaria elimination. Reflections from the Solomon Islands  - Albino Bobogare
• Papua New Guinea: Working with communities for elimination - Paison Dakulala
• Where are people located when mosquitoes are biting in Solomon Island villages? - Edgar JM Pollard
• Empowering communities in East New Britain, PNG to eliminate PF malaria. - Lisa Davidson

Q&A Panel Discussion

• Prospects of P.Vivax Elimination - Cindy Chu
• P. vivax elimination: Challenges and Opportunities - Ivo Mueller
• Drugs for malaria elimination - G Dennis Shanks
• A mass administration of Dihydroartemisinin-Piperaquine in Savannakhet, Lao PDR: A cluster randomised controlled trial. - Mayfong Mayxay
• Malaria elimination process in China  - Qi Gao
• Molecular surveillance to inform elimination strategies - Sarah Auburn
• An inconvenient truth: the rise of knowlesi malaria in the elimination era - Nick Anstey
• Global economic costs due to P. vivax malaria treatment and the cost-benefit of radical cure - Angela Devine

Q&A Discussion

The Congress would like to acknowledge that the follow speaker is an Australia Awards Health Security Fellow:

• Mayfong Mayxay

• Malaria elimination in India - Preeti Sudan
• National Leadership for Malaria Elimination: Lessons from southern Africa - Richard Nchabi Kamwi
• To be provided - Tenneth Dalipada
• Perspectives from Papua New Guinea - Paison Dakulala
• Unprecedented increase of malaria in Venezuela: a regional menace - Adriana Tami
• Challenges of malaria elimination in Myanmar  - Aung Thi

• Primaquine radical cure  of malaria - Trials and tribulations - Ric Price
• The importance of preventing P. vivax relapse in Papuan children - Jeanne Rini Poespoprodjo
• The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: an individual patient pooled analysis - Rob J Commons
• Risks in Anti-Relapse Primaquine Therapy with G6PD Deficiency - John Kevin Baird
• Safety of Unsupervised 14 days Primaquine for the Radical Cure of P. vivax in Papua, Indonesia - Kamala Ley-Thriemer

Followed by Q&A discussion

• Investigating the magnitude and drivers of persistent Plasmodium infections in east and west African communities - Fredros Okumu
• Understanding human, parasite, vector and environmental interactions driving residual malaria transmission in Papua New Guinea - Moses Laman
• Vector control at the cross-roads in Asia-Pacific Region: public health entomology and persistent ‘residual’ malaria transmission - Jeffrey Dr Hii
• Effective malaria control of “outdoor-biting” vectors with an indoor intervention  - Tanya L Russell
• Mass drug administrations for falciparum malaria elimination in Myanmar, Vietnam, Cambodia, and Laos - Lorenz von Seidlein
• Economic-Epidemiological Modelling of Mass Drug Administration for Malaria - Lisa White
• Mass Drug Administration to accelerate malaria elimination in Myanmar; a cluster-randomised trial in a region with artemisinin resistant falciparum malaria. - Frank Smithuis

Panel Discussion: "How does context affect participation? APMEN perspectives"
Facilitator: Dr Effie Espino, Asia Pacific Malaria Elimination Network

• Dr Rose Nani, Ministry of Health, Malaysia
• Prof Gao Qi, Jiangsu Institute of Parasitic Diseases

• Process of optimising the roles of integrated community malaria volunteers in malaria elimination-Myanmar experience - HTIN KYAW THU
• Engaging non-formal private providers in Myanmar to accelerate malaria elimination efforts - M James Eliades
• The role of community based health workers in providing health services to hard to reach populations in the Southern provinces of Laos PDR towards achieving the national goal of eliminating malaria by 2030 - RONALDO SIANO ESTERA
• To be provided - Annemarie Meyer
• We achieve more together: The SADC Elimination 8’s use of advocacy to mobilize political will and secure sustainable financing for a malaria-free future in Southern Africa - Phelele Fakudze
• Thailand leverages geo-referenced malaria information to increase local ownership and funding for malaria elimination - Prayuth Sudathip

Investigating functional antibody mechanisms against Plasmodium falciparum sporozoites in naturally-acquired and RTS,S vaccine-induced immunity    - Liriye Kurtovic (abs# 73)

• Host erythrocyte phospho-signalling during infection with Plasmodium falciparum - Jack Adderley
• On the origins and spread of differences in human host preference in a group of malaria transmitting mosquitoes - Luke Ambrose
• Quantification of parasite clearance before and after antimalarial treatment in Plasmodium infected mice - Rosemary Aogo
• Investigating how acetylation of histone variant PfH2A.Z and PfH2B.Z affects their chromatin localisation in Sir2A knockout parasites - Mohd Suffian Azizan
• Validation of qPCR assays to quantify P. falciparum parasitemia in induced blood stage malaria studies - Emma Ballard
• Importance of household-level risk factors in explaining micro-epidemiology of asymptomatic malaria infections in Ratanakiri Province, Cambodia - Melanie Bannister-Tyrrell
• Parasite genomic surveillance in malaria control and elimination - Alyssa Barry
• Conserved and divergent mechanisms of merozoite invasion into the human erythrocyte: insights from the non-Laverania malaria parasites - Jake Baum
• The social co-relation between malaria, water, sanitation and hygiene among internally displaced people {IDPs} and illegal migrant health: An epidemiological review of social implication of migration and population health in sub-sahara Africa  - Benjamin Bob
• Targeting host hepatocytes to clear Plasmodium infections and induce immunity - Justin Boddey
• Improving fetal growth by restoring placental function in malaria in pregnancy - Philippe Boeuf
• A genetic resistance trap in malaria parasites: exploiting the differential metabolism of the parasite between its two hosts - Hayley D Buchanan
• Assessment of health-care system and its potential impact on the persistence of malaria transmission in selected areas of North – Western and Southern regions of Tanzania - Frank Chacky
• Isolation of naturally acquired human monoclonal antibodies to Plasmodium vivax adhesin PvRBP2b reveals novel inhibitory epitopes - Li Jin Chan
• Antibody targets on the surface of P. falciparum-infected erythrocytes that are associated with immunity to severe malaria in young children - Jo-Anne Chan
• Plasmodium vivax Reticulocyte Binding Protein 2p1: Functional activity and host immune response - Anongruk Chim-ong
• Mechanistic population modelling of primaquine-induced haemolysis in G6PD deficient patients - Palang Chotsiri
• The nocturnal biting profile of Anopheles farauti in Far North Queensland, Australia - Weng K Chow
• Protein turnover dynamics in artemisinin resistant parasites and the contribution of K13 to protein homeostasis - Simon Cobbold
• Resolving clinically overt cerebral malaria by inhibiting accumulation of Ly6C^lo pathogenic monocytes in brain microvasculature - Amy Cohen
• The haematological response following chloroquine treatment of Plasmodium vivax with or without primaquine: a pooled analysis of individual patient data - Robert J Commons
• High prevalence of Plasmodium malariae and Plasmodium ovale in co-infections with Plasmodium falciparum in asymptomatic malaria parasite carriers in Southwest Nigeria - Richard Culleton
• Importance of functional antibodies in protection of pregnant women from malaria - Timon Damelang
• Economic costs of P. vivax episodes: a multi-country comparative analysis using primary trial data - Angela Devine
• Can triple artemisinin-based combination therapies (TACTs) be a future treatment for Plasmodium falciparum malaria? A mathematical perspective - Saber Dini
• Malaria getting in shape for sex - Matthew Dixon
• Var genes expressed in severe malaria - Michael Duffy
• Reporting of antimalarial adverse drug reactions by community pharmacists in Sudan - Elkhanssa Mrs Elhag
• Challenges in the frontline barangay health workers socio-political forces and malaria elimination in the Philippines   - MARIO BAQUILOD
• Knowledge and attitudes of prevention about malaria in travelers with destination to risk zones, that they start of terraporches or Chiclayo  - Virgilio E Failoc Rojas
• Liver-resident memory T cells can be harnessed for highly efficient protection against malaria - Daniel Fernandez-Ruiz
• Investigating malaria-specific T cells responses in the brain of mice with ECM   - Nazanin Ghazanfari
• Development of Plasmodium-specific liver resident-memory CD8+ T cells after Heat-Killed Immunization - Sonia Ghilas
• A 4-cyano-3-methylisoquinoline inhibitor of Plasmodium falciparum growth targets the sodium efflux pump PfATP4. - Paul Gilson
• Naturally acquired human antibodies against Reticulocyte-Binding domains of Plasmodium vivax Proteins, PvRBP2c and PvRBP1a, exhibit binding-inhibitory activity - Enna Dogra Gupta
• Insecticide resistance monitoring and susceptibility of malaria vectors over the past 10 years in Zanzibar - Khamis Haji
• Preventing artemisinin resistance emergence in the Guiana Shield: an innovative approach for a specific context - Helene Hiwat-Van Laar
• Requirements for the formation of liver-resident memory T cells and their role in protection from malaria. - Lauren E Holz
• Peripheral cytokine profiles during pregnancy in women exposed to Plasmodium falciparum infection - tatiana hountohotegbe
• Trends of antimalarial efficacy and molecular markers of drug resistance after more than a decade of using artemisinin-based combination therapy in mainland Tanzania - Deus S. Ishengoma
• Sources and processes of knowledge about the malaria parasitology: A systematic review of the update  - Zahirul Islam
• Using genomic epidemiology as a frontline malaria intervention - Christopher G Jacob
• Mitigating malaria reintroduction in Malaysia - Jenarun Jelip
• Reactivation of vaccine-induced carbohydrate-specific memory B cells by rodent malaria infection - Hayley Joseph
• Factors associated with non-utilisation of long lasting insecticidal bed-nets (LLIN) among household members in malaria-endemic areas of Bangladesh. - M. Moktadir Kabir
• Exploration of distinctive Menyanthes trifoliata as generated green Nanoparticles-report their lethal toxicity against Anopheles stephensi - Siva Kamalakannan
• Lessons learned from the malaria eradication campaign and implications for intensified malaria control in Burundi - Walter Kazadi Mulombo
• High risk of Plasmodium vivax malaria following splenectomy in Papua, Indonesia - Steven Kho
• The role of parasite clearance in malaria infection - David Khoury
• Could a triple-hit hypothesis explain the pathway from malaria in pregnancy to adverse child neurodevelopmental outcomes? - Harriet L. S. Lawford
• Investigating alternative splicing in stage differentiation of apicomplexan parasites - Vern Lee
• Malaria elimination in the Comoros archipelago : yes we can - Jean-François Lepère
• Regimen optimization for malaria chemoprophylaxis agents using pharmacokinetics and pharmacodynamics considerations   - Qigui Li
• Defining naturally acquired antibody kinetics and longevity to Plasmodium vivax antigens in western Thailand - Zoe Shih-Jung Liu
• The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine for uncomplicated falciparum malaria in adults and children in North Sumatra, Indonesia - Inke ND Lubis
• Malaria effector proteins traffic via a distinct ER interactome that licenses parasite virulence - Danushka S Marapana
• Hidden parasite hindrances to eradication of Plasmodium vivax - Miles B Markus
• The natural substrates and normal physiological role of the malaria parasite’s ‘chloroquine resistance transporter’ - Sarah Shafik
• Characterising the regulatory effects of splice variants of transporters - Vicky Zhang
• Is artemisinin-induced parasite growth retardation in blood-stage Plasmodium falciparum a potential contributor to drug-resistance? - James M McCaw
• Development of novel defence peptides from human platelet factor 4 that kill Plasmodium by selective membrane disruption - Brendan J McMorran
• Spatial epidemiology of malaria in Tak Province, Thailand, 2012-2015 - Chris Erwin G Mercado
• Evaluation of Uni-Gold^TM malaria Ag P.f./PAN from Trinity Biotech, a rapid test for the detection of malaria - Ferda Yantiri-Wernimont
• Lacak malaria: malaria surveillance model in remote area use mobile phone for rapid-reporting - Firmansyah Mr Mustafa
• Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women - Ritah F Mutagonda
• Use of long-lasting Insecticides treated nets among the mobile and migrant populations - Cho Naing
• Contribution of mass testing, treatment and tracking in the reduction of malaria prevalence among under 15 children in the Pakro sub district, Ghana - Ignatius C Ndong
• Maintenance of acquired immunity to malaria in the pre-elimination setting of Southeast Myanmar.    - Katherine O'Flaherty
• Hematological changes in malaria infected children under 5 years on Moringa oleifera nutrient supplement in Nigeria - BERNICE B.A OGOLO
• Impact of improved malaria control on the force of infection of P. falciparum and P. vivax in young Papua New Guinean children - Maria Ome-Kaius
• Red blood cell complement regulatory proteins are lost during both vivax and falciparum malarial anaemia and are not associated with protective complement-fixing antibodies - Damian Oyong
• Activity of endectocides ivermectin and moxidectin against Anopheles farauti in treated pigs - Cielo Pasay
• Spectacular decline of malaria on Malaita: A review of laboratory-based data - HelenP Polosovai
• Understanding adherence to P. vivax malaria radical cure in a cluster randomized trial: a mixed methods study - Annisa Rahmalia
• Immunity to Plasmodium falciparum erythrocyte membrane protein1 and severe malaria in Papua New Guinea - Janavi S Rambhatla
• Targets of complement fixing antibodies in immunity against malaria – new leads for vaccine development - Linda Reiling
• Extreme diversity and population structure of var genes can explain why immunity to the blood stages of Plasmodium falciparum is non-sterilizing - Shazia Ruybal-Pesántez
• Modulation of bystander red blood cell metabolism by Plasmodium falciparum - Anna E Sexton
• A phase Ia/b study to assess the safety and immunogenicity of placental malaria vaccine candidate: Preliminary results of the PRIMALVAC trial - Sodiomon Bienvenu Sirima
• Targeted phenotypic screening in Plasmodium falciparum and Toxoplasma gondii reveals novel modes of action for MMV malaria box molecules - Gowtham Subramanian
• Modulation of Plasmodium susceptibility to artemisinin by variants of adaptin subunit AP2μ and ubiquitin carboxyl-terminal hydrolase UBP1. - Colin Sutherland
• Identification of gene regulatory elements in the malaria parasite Plasmodium falciparum - Jingyi Tang
• Membrane feeding assay; a tool to study malaria transmission in Anopheles farauti mosquitoes in Papua New Guinea - Lincoln Timinao
• Relationship between occupation and behavior and malaria in Sumba Tengah District  - Chandra UR Landuwulang
• Co-expression of variant surface antigens in Rosetting of Plasmodium falciparum  - Digjaya Utama
• What is the best method to measure pre-treatment P. falciparum burden in human challenge studies? - Lachlan Webb
• Retargeting the antibiotic azithromycin as an antimalarial with dual mechanisms of action - Danny Wilson
• Defining a structural epitope within Plasmodium vivax PvDBP as a vaccine candidate against Plasmodium falciparum placental malaria - Stephanie K Yanow
• “Overview of mobility and universal health access - what do we know” - Shreehari Acharya
• In vivo mechanisms of antibody-mediated parasite control during blood-stage Plasmodium infection in mouse models - Jasmin Akter
• Characterizing functional antibody responses in malaria in pregnancy    - Anjaleena Anthony
• Plasmodium falciparum conditional knockout parasites expressing exported NanoLuc luciferase allow investigation of events that precede merozoite egress - Mauro F. Azevedo
• Interrelationship between Plasmodium development and host cell eryptosis - Coralie Boulet
• Relationship between CYP2D6 allelic types, predicted phenotypes and outcome of primaquine presumptive anti-relapse therapy in Australian Defence Force personnel deployed to Papua New Guinea and East Timor - Nanhua Chen
• Bioassay guided isolation and identification of antimalarial compound in Clausena lansium (Lour.) Skeels leaves - Kamonlawan Chomchopbun
• Drug resistance in malaria: investigating the mechanisms of resistance to doxycycline and artemisinin - Emily M Crisafulli
• A phenotypic screen of the MMV Malaria box identifies inhibitors of the bioluminescent reporter, Nanoluciferase in Plasmodium falciparum - Madeline G Dans
• Characterization of the Plasmodium falciparum aspartyl proteases DNA-damage inducible protein 1 and Plasmepsin 7   - Bethany K Davey
• Chemical Probes to Investigate the Underlying Mechanism of New Permeability Pathways (NPP) in P. falciparum - Benjamin K Dickerman
• Risk factors associated with malaria infection among patients who seek health care through the public and community sectors in malaria endemic townships of ayeyarwady region myanmar - Nang Aung
• Monitoring susceptibility of Plasmodium falciparum isolates to artemisinin combinations in Ninh Thuan Province, south-central Vietnam - Marina Chavchich
• Understanding the rhoptry proteins in Plasmodium - nutrient channels, drug targets and much more... - Smitha Sudhakar
• Development of a SNP barcode for high resolution monitoring of P. vivax transmission dynamics in Papua New Guinea - Abebe A Fola
• Modeling malaria transmission dynamics with heterogeneity in risk distribution - Gabriela Gomes
• Malaria immunity towards VAR2CSA correlate to protection towards placental parasitemia - Wina Hasang
• Activity characterization and classification of anti-plasmodial compounds. - Sandra Duffy
• Antifolate screening against Plasmodium vivax using a novel bacterial model - Sumalee Kamchonwongpaisan
• The ‘Super Malaria’ overrunning northward in Laos! - Shigeyuki Kano
• The Search for a Thermostable Rapid Diagnostic Test (RDT) Positive Control for Military and Clinical Trial Use in Malaria Endemic Countries - Patricia Lee
• _{Screening of patients and their companions in health facility surveys: Enhancing surveillance for malaria elimination in the Philippines} - Ralph Reyes
• Prevalence of chloroquine and sulfadoxine-pyrimethamine drug resistance-associated mutations in Plasmodium falciparum and Plasmodium vivax isolates of Palawan, Philippines - Alison Paolo Bareng
• NMR reveals conformational properties of the Circumsporozoite protein central repeats - Chris MacRaild
• Cloning and Expression of Artemisia annua Farnesyl Pyrophosphate Synthase (FPS) in Saccharomyces cerevisiae for Production of Semi-Synthetic Artemisinin   - Fifi Fitriyah Masduki
• GSK3β: a plausible therapeutic target of medicinal plant-derived bioactive compounds for cytokine modulation during malarial infection - Hasidah Mohd Sidek
• Establishing mobile outreach teams (mots) for strengthening active case detection in vietnam 2017-2020 - Ha Nam Nguyen
• Plasmodium vivax reticulocytes binding proteins (PvRBP) are immune targets in clinical isolates from Timika, Papua, Indonesia - Rintis Noviyanti
• Metal Ion Activation. Moving on from the artemisinins - Chris J Parkinson
• Characterisation of artemisinin-induced dormancy using a controlled human malaria infection - Chris L Peatey
• Understanding the role of IgM+ memory B cells in immunity to malaria using a mouse model of infection  - Halina M Pietrzak
• Performance of CareStart RDT in determining the status of G6PD deficiency in anemic sample - Hisni Rahmat
• NgenIRS product pipeline and the future of insecticide resistance management for IRS - Molly Robertson
• DNA aptamers as potential antimalarial drugs: Isolation of DNA aptamers against enzymes of the methylerythritol phosphate pathway - Carlota Roca Martinez
• Evaluation of health facility-based surveys to monitor malaria transmission in a pre-elimination setting, Indonesia - Henry S Saridah
• Death following severe malaria in the elimination phase in Bangladesh - Abdullah Abu Sayeed
• Relationship between relapse and weight-adjusted dose of primaquine in Korean vivax malaria - Hye Seong
• An entomological surveillance planning tool to improve entomological intelligence for evidence-based vector control decision-making towards malaria elimination - Allison Tatarsky
• Application of an automated hematology analyzer XN-30 for discovery and development of antimalarial drugs in vitro - Takahiro Tougan
• Background genetics of parasites contributes to antifolate resistance - Chairat Uthaipibull
• A pilot study using droplet digital PCR for quantification of gametocytes - Claire YT Wang
• On Estimating Malaria Parasite Density using the Assumed White Blood Cell (WBC) Count of 8,000 cells/microL: Preliminary Results - Elke Wynberg
• Malaria elimination strategies and progress in Yunnan Province, PR China - Jianwei Xu

Interactive session between civil society, government, development partners scientists and other interested parties on What does effective disease integration look like form community perspectives? Facilitated by Mr Louis de Gama and Mr Shree Acha

• Progress towards malaria elimination in Vietnam - Ngo Duc Thang
• Cambodia’s Operational Task Force for Malaria Elimination and Diagnosis & Treatment Working Group - Dysoley Lek
• Malaria elimination in Lao PDR: Challenges associated with population mobility - Sengchanh Kounnavong
• To be provided - Khin Nan Lon

Followed by Q&A Discussion

The Congress would like to acknowledge that the follow speaker is an Australia Awards Health Security Fellow:

• Ngo Duc Thang
• Sengchanh Kounnavong

• Nikkei Asian conference on communicable diseases: unprecedented innovative public-private-academia platform for Japan’s contribution to malaria elimination   - Chika Saito
• Myth-busters: The private sector as essential malaria elimination partners   - Lorina McAdam
• Making room for innovation in a resource-constrained environment - Alexandra Cameron
• Micro-epidemiology: Research designs for malaria elimination - Melanie Bannister-Tyrrell
• Reaching mobile, migrant populations: Tales of the unexpected from four country contexts - Jamie Eliades
• Tackling global health security and antimicrobial resistance with new tools to support integrated approaches to fever management - Katerina Galluzzo

• Malaria elimination in India: roadblocks and roadmap - Neena Valecha
• The success of an ecosystem approach to malaria elimination in India - Vikas Goswami
• Malaria elimination crossroads in Vanuatu: holding the line as the health sector evolves and vertical funding diminishes - Len Tarivonda
• Reducing malaria in Solomon Islands: lessons for effective aid - Camilla Burkot

• Tafenoquine for malaria prevention - Geoffrey Dow
• Investigating functional antibody mechanisms against Plasmodium falciparum sporozoites in naturally-acquired and RTS,S vaccine-induced immunity    - Liriye Kurtovic
• An implementation trial to explore the feasibility, effectiveness, acceptability and cost of a community based system for seasonal malaria prophylaxis (SMC) in selected LGAs in Katsina State, Northern Nigeria - James Tibendarana
• Prevention at scale: results from a three-year implementation research project expanding access to seasonal malaria chemoprevention in seven Sahelian countries (ACCESS-SMC) - Diego Moroso
• Collating and Modelling Malaria data to support national decision making - Alinane Munyenyembe
• Why we need a vaccine to eliminate malaria in areas with intense transmission and how we intend to use a PfSPZ vaccine to achieve this - Steve Hoffman